Month: April 2022

Apr 21 2022

Uncategorized

Teva’s long-acting schizophrenia drug rejected by FDA – – pharmaphorum

by Clinical Editor

No Comments

Teva’s long-acting schizophrenia drug rejected by FDA –  pharmaphorum FDA declines to move forward with schizophrenia treatment  Healio FDA Rejects Schizophrenia Tx; ADHD & Mental Health; Eating Disorder Treatment Scarce  Medpage Today Teva...

Apr 21 2022

Uncategorized

FDA declines to move forward with schizophrenia treatment

by Clinical Editor

No Comments

The FDA has issued a Complete Response Letter for the New Drug Application for risperidone extended-release injectable for subcutaneous use, a schizophrenia treatment, Teva Pharmaceuticals and …

Apr 21 2022

Uncategorized

FDA Rejects Schizophrenia Tx; ADHD & Mental Health; Eating Disorder Treatment Scarce

by Clinical Editor

No Comments

The FDA hit Teva Pharmaceuticals and MedinCell with a complete response letter in regard to their new drug application for the schizophrenia treatment TV-46000/mdc-IRM (risperidone extended-release …

Apr 21 2022

Uncategorized

Teva’s long-acting schizophrenia drug rejected by FDA

by Clinical Editor

No Comments

Setback for Teva and French partner MedinCell as FDA turns down marketing application for long-acting schizophrenia injectable TV-46000 …

Apr 21 2022

Uncategorized

Man With Schizophrenia Missing in La Mirada

by Clinical Editor

No Comments

A 47-year-old man who authorities say has been diagnosed with schizophrenia has been reported missing in La Mirada and detectives from the Los Angeles County Sheriff’s Department Missing Persons Unit...

Apr 21 2022

Uncategorized

A path to promising treatments for schizophrenia through gene variants

by Clinical Editor

No Comments

Over the last 15 years, researchers at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have been working to decode the biological causes of...

Apr 20 2022

Uncategorized

Inside Schizophrenia Podcast: Tardive Dyskinesia in Schizophrenia – PsychCentral.com

by Clinical Editor

No Comments

Inside Schizophrenia Podcast: Tardive Dyskinesia in Schizophrenia  PsychCentral.com

Apr 20 2022

Uncategorized

Exploring the link between schizophrenia and COVID-19 – MD Linx

by Clinical Editor

No Comments

Exploring the link between schizophrenia and COVID-19  MD Linx

Apr 20 2022

Uncategorized

Landmark study reveals clearest genetic signals yet for schizophrenia risk

by Clinical Editor

No Comments

In a landmark genetic study of more than 121,000 people, an international consortium called SCHEMA, led by researchers at the Broad Institute of MIT and Harvard, has identified extremely rare...

Apr 20 2022

Uncategorized

FDA delays approval for Teva schizophrenia drug

by Clinical Editor

No Comments

Teva and its French partner MedinCell have received a Complete Response Letter, meaning that the New Drug Application cannot be approved in its present form. The approval of Teva Pharmaceutical...